News Center
Share the latest news with you
Dr. Yanhua Xu
2025-03-11
Dr. Yanhua Xu, MD, owns eighteen years of experience in oncology clinic and global clinical trials. She was SVP of NewBay Pharma, leading the strategy and implementation of global clinical development. Prior to that, she was medical director of Global R&D in AstraZeneca, responsible for global clinical trials of immuno-oncology pipeline in advanced liver cancer. Dr. Xu got her medical degree from Fudan University.
About Us
News Recommendation
Copyright (c) 2013 IMPACT Therapeutics. All Rights Reserved 沪ICP备2024107649号 互联网药品信息证书编号:(沪)-非经营性-2025-0012 /Clinical Trial Privacy Notice / Privacy Notice / Legal Statement
